Literature DB >> 28471927

The Experiences of Medical Marijuana Patients: A Scoping Review of the Qualitative Literature.

Jennie Ryan, Nancy Sharts-Hopko.   

Abstract

Medical marijuana is now legal in more than half of the United States but remains federally prohibited and classified as a schedule 1 drug. The chemical compounds in marijuana are known neuroprotectants; however, their clinical efficacy and safety have not been proven. Many healthcare providers remain unaware of the therapeutic potential of marijuana and its adverse effects. The conflicting laws and lack of guidance from healthcare professionals can lead to confusion and frustration for patients seeking this medication. Multiple factors contribute to the unique and varied experiences of medical marijuana patients. Because more individuals with neurological disorders seek therapeutic marijuana, it is important for healthcare professionals to understand their distinctive experiences. Qualitative research methodology is ideal to capture the thick descriptions of these experiences. This review examines the qualitative research exploring the experiences of medical marijuana patients and discusses common themes across all studies.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28471927     DOI: 10.1097/JNN.0000000000000283

Source DB:  PubMed          Journal:  J Neurosci Nurs        ISSN: 0888-0395            Impact factor:   1.230


  9 in total

1.  Qualitative Analysis of Cannabis Use Among Older Adults in Colorado.

Authors:  Julie Bobitt; Sara H Qualls; Melissa Schuchman; Robert Wickersham; Hillary D Lum; Kanika Arora; Gary Milavetz; Brian Kaskie
Journal:  Drugs Aging       Date:  2019-07       Impact factor: 3.923

2.  Denying renal transplantation to an adolescent medical cannabis user: An ethical case study.

Authors:  Jennie E Ryan; Maia Noeder; Christine Burke; Samuel C Stubblefield; Salwa Sulieman; Elissa G Miller
Journal:  Pediatr Transplant       Date:  2019-05-23

3.  Parents' experiences using medical cannabis for their child.

Authors:  Jennie E Ryan; Suzanne C Smeltzer; Nancy C Sharts-Hopko
Journal:  Nurs Outlook       Date:  2020-04-23       Impact factor: 3.250

4.  Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida.

Authors:  John S Luque; Arinze Nkemdirim Okere; Carlos A Reyes-Ortiz; Paula M Williams
Journal:  Complement Ther Med       Date:  2021-01-15       Impact factor: 2.446

Review 5.  A qualitative review of cannabis stigmas at the twilight of prohibition.

Authors:  Matt Reid
Journal:  J Cannabis Res       Date:  2020-12-07

6.  Involvement of the endocannabinoid system in the inhibition of Sindbis virus replication: a preliminary study.

Authors:  Juan L Rodriguez; Joseph A Lopez; J Jordan Steel
Journal:  J Cannabis Res       Date:  2021-04-23

7.  Exploring the Use of Medical Marijuana for Supportive Care of Oncology Patients.

Authors:  Deena Damsky Dell; Daniel P Stein
Journal:  J Adv Pract Oncol       Date:  2021-03-01

8.  Perceived Stigma of Patients Undergoing Treatment with Cannabis-Based Medicinal Products.

Authors:  Lucy J Troup; Simon Erridge; Beata Ciesluk; Mikael H Sodergren
Journal:  Int J Environ Res Public Health       Date:  2022-06-19       Impact factor: 4.614

9.  Willingness to Participate in Longitudinal Research Among People with Chronic Pain Who Take Medical Cannabis: A Cross-Sectional Survey.

Authors:  Marcus A Bachhuber; Julia H Arnsten; Joanna L Starrels; Chinazo O Cunningham
Journal:  Cannabis Cannabinoid Res       Date:  2018-03-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.